Common clinical conditions – age, low BMI, ritonavir use, mild renal impairment – affect tenofovir pharmacokinetics in a large cohort of HIV-infected women
Sanjiv M. Baxi(Johns Hopkins University), Monica Gandhi(University of California, San Francisco), Howard Minkoff(Twitter (United States)), Ruth M. Greenblatt(Public Health Department), Peter Bacchetti(University of California, San Francisco), Kathryn Anastos(Albert Einstein College of Medicine), Michael G. Shlipak(San Francisco VA Health Care System), Mardge H. Cohen(John H. Stroger, Jr. Hospital of Cook County), Yong Huang(University of California, San Francisco), Rebecca Scherzer(San Francisco VA Health Care System), Mary Young(Georgetown University), Stephen J. Gange(Johns Hopkins University)
Cited by 68
Related Papers
Liver Transplantation for Hepatocellular Carcinoma: Expansion of the Tumor Size Limits Does Not Adversely Impact Survival
|Hepatology|2001|2.3k
Cystatin C and the Risk of Death and Cardiovascular Events among Elderly Persons
|New England Journal of Medicine|2005|1.2k
Effect of Early versus Deferred Antiretroviral Therapy for HIV on Survival
|New England Journal of Medicine|2009|1.1k
Cystatin C versus Creatinine in Determining Risk Based on Kidney Function
|New England Journal of Medicine|2013|968